Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy

Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy

Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of oncological nanotechnology has provided a novel drug delivery system for erlotinib. The aims of this current invest...

Full description

Bibliographic Details
Main Authors: Wafa K. Fatani, Fadilah S. Aleanizy, Fulwah Y. Alqahtani, Mohammed M. Alanazi, Abdullah A. Aldossari, Faiyaz Shakeel, Nazrul Haq, Hosam Abdelhady, Hamad M. Alkahtani, Ibrahim A. Alsarra
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Molecules
Subjects:
polyamidoamine dendrimers
erlotinib
non-small-cell lung cancer
cytotoxicity
Online Access:https://www.mdpi.com/1420-3049/28/9/3974

Internet

https://www.mdpi.com/1420-3049/28/9/3974

Similar Items